Phase II, Open-label, Parallel 2-arm, Multi-center

Explore clinical trials studying Phase II, Open-label, Parallel 2-arm, Multi-center. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Phase II, Open-label, Parallel 2-arm, Multi-center trial results

Active, Not Recruiting

A Phase II Randomized Study of Gemcitabine and Nab-paclitaxel in Combination With S- 1/LV (GASL) or Oxaliplatin (GAP) as First-line Treatment for Metastatic Pancreatic Cancer

NCT05026905

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung City, Taiwan

China Medical University Hospital Taichung, Taiwan

Taichung Veterans General Hospital Taichung, Taiwan

National Cheng Kung University Hospital Tainan, Taiwan

View Trial Details

Phase II, Open-label, Parallel 2-arm, Multi-center

Phase II, Open-label, Parallel 2-arm, Multi-center trial results

A Phase II Randomized Study of Gemcitabine and Nab-paclitaxel in Combination With S- 1/LV (GASL) or Oxaliplatin (GAP) as First-line Treatment for Metastatic Pancreatic Cancer

Related conditions